Advertisement

Reactions Weekly

, Volume 1697, Issue 1, pp 3–3 | Cite as

Acute acalculous cholecystitis associated with alemtuzumab

Clinical study
  • 44 Downloads

References

  1. 1.
    Croteau D, et al. Acute acalculous cholecystitis: A new safety risk for patients with MS treated with alemtuzumab. Neurology : 30 Mar 2018. Available from: URL: http://doi.org/10.1212/WNL.0000000000005422.
  2. 2.
    Muraro PA, et al. Rare side effects of alemtuzumab remind us of the need for postmarketing surveillance. Neurology : 30 Mar 2018. Available from: URL: http://doi.org/10.1212/WNL.0000000000005409.

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations